繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Icecure Medical Q2 2024 GAAP EPS $(0.06) Beats $(0.07) Estimate, Sales $1.01M Beat $925.50K Estimate

2024-08-20 20:39

Icecure Medical (NASDAQ: ICCM) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. The company reported quarterly sales of $1.01 million which beat the analyst consensus estimate of $925.50 thousand by 9.24 percent. This is a 7.90 percent increase over sales of $937.00 thousand the same period last year.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。